Table: Aska Pharmaceutical Holdings -Q1 group results

ASKA Pharmaceutical Holdings

04/11/2025 06:31

Nov 4 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             17.64               16.35            75.00    
                 (+7.9 pct)          (+2.1 pct)       (+16.9 pct) 
  Operating          1.48                1.76             6.80    
                 (-15.9 pct)         (+3.1 pct)       (+27.5 pct) 
  Recurring          1.62                1.81             6.80    
                 (-10.6 pct)         (+0.2 pct)       (+33.1 pct) 
  Net                1.24                1.27             5.20    
                 (-2.3 pct)          (-10.9 pct)      (+1.9 pct)  
  EPS             43.88 yen           44.95 yen       183.44 yen  
  Ann Div                             55.00 yen        55.00 yen  
  -Q2 div                             25.00 yen        27.00 yen  
  -Q4 div                             30.00 yen        28.00 yen  
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T